Skip to Content

Biogened SA - Stock Quote BGD

Rating as of

Morningstar's Biogened SA Stock Analysis

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - BGD

Biogened SA's Company Profile

Business Description

Biogened SA is a Polish cosmetic company. The company defined its key areas of activity, concentrated its efforts on the development of neurological and psychiatric products. It also develops, produces and distributes ingredients, safe and effective dermo cosmetics under the Dermedic brand.

Contact
Ulica Pojezierska 99
Lodz, 91-342, Poland
T +48 426513152
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2019
Stock Type
Employees 181